Catherine Lunven

559 total citations
17 papers, 462 citations indexed

About

Catherine Lunven is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Catherine Lunven has authored 17 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catherine Lunven's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Catherine Lunven is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Catherine Lunven collaborates with scholars based in France, United States and Germany. Catherine Lunven's co-authors include Stephen E. O'Connor, Jean‐Marc Herbert, Jean-Pascal Hérault, Catherine Berry, Gilbert Lassalle, J.M. Altenburger, Paul Schaeffer, Zsolt Böcskei, Franck Poitiers and Donogh P. O'Brien and has published in prestigious journals such as Blood, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Catherine Lunven

17 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Lunven France 10 188 139 114 112 109 17 462
Ger‐Jan Sanderink France 10 94 0.5× 150 1.1× 136 1.2× 43 0.4× 29 0.3× 12 712
H. Ferres United Kingdom 13 108 0.6× 108 0.8× 31 0.3× 106 0.9× 74 0.7× 38 470
H. Narjes Germany 11 66 0.4× 69 0.5× 13 0.1× 55 0.5× 75 0.7× 17 461
Patricia W. Bedard United States 10 57 0.3× 81 0.6× 161 1.4× 139 1.2× 173 1.6× 10 532
Janice Rischke Canada 11 84 0.4× 149 1.1× 104 0.9× 104 0.9× 18 0.2× 16 396
Richard T. Dean United States 16 63 0.3× 95 0.7× 48 0.4× 17 0.2× 115 1.1× 20 695
Yvonne Pak United States 12 59 0.3× 74 0.5× 45 0.4× 148 1.3× 41 0.4× 17 534
Maria T. Stranieri United States 16 85 0.5× 137 1.0× 46 0.4× 272 2.4× 205 1.9× 26 642
Valeria Chu United States 15 39 0.2× 163 1.2× 80 0.7× 177 1.6× 100 0.9× 31 544
Dirk Garmann Germany 13 23 0.1× 135 1.0× 50 0.4× 109 1.0× 82 0.8× 30 552

Countries citing papers authored by Catherine Lunven

Since Specialization
Citations

This map shows the geographic impact of Catherine Lunven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lunven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lunven more than expected).

Fields of papers citing papers by Catherine Lunven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Lunven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lunven. The network helps show where Catherine Lunven may publish in the future.

Co-authorship network of co-authors of Catherine Lunven

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lunven. A scholar is included among the top collaborators of Catherine Lunven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lunven. Catherine Lunven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dürrbach, Antoine, Jean‐Charles Gautier, Catherine Lunven, et al.. (2021). Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy. Clinical Transplantation. 35(9). e14408–e14408. 3 indexed citations
2.
Lunven, Catherine, et al.. (2017). Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants. The Journal of Clinical Pharmacology. 57(6). 747–750. 2 indexed citations
3.
Lunven, Catherine, et al.. (2016). Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide. Therapeutic Drug Monitoring. 38(4). 471–482. 14 indexed citations
4.
5.
6.
Altenburger, J.M., Gilbert Lassalle, Zsolt Böcskei, et al.. (2004). SSR182289A, a selective and potent orally active thrombin inhibitor. Bioorganic & Medicinal Chemistry. 12(7). 1713–1730. 117 indexed citations
7.
Millet, L., Catherine Lunven, Catherine Berry, et al.. (2003). Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 304(2). 567–574. 18 indexed citations
8.
Lassalle, Gilbert, Catherine Lunven, J.M. Altenburger, et al.. (2002). SSR182289A, a Novel, Orally Active Thrombin Inhibitor: In Vitro Profile and ex Vivo Anticoagulant Activity. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1189–1198. 20 indexed citations
9.
Berry, Catherine, et al.. (2000). Anticoagulant Activity and Pharmacokinetic Properties of a Sub-cutaneously Administered Mixed Micellar Formulation of Argatroban in Experimental Animals. Thrombosis and Haemostasis. 84(8). 278–285. 4 indexed citations
10.
Lunven, Catherine, et al.. (2000). Role of clot‐associated (‐derived) thrombin in cell proliferation induced by fibrin clots in vitro. British Journal of Pharmacology. 129(5). 1021–1027. 11 indexed citations
11.
12.
Lunven, Catherine, et al.. (1998). Platelet Aggregation Induced In Vitro by Rabbit Plasma Clot-associated Thrombin, and Its Inhibition by Thrombin Inhibitors. Thrombosis and Haemostasis. 80(11). 840–844. 8 indexed citations
13.
Lunven, Catherine, et al.. (1998). Ecarin Clotting Time: a Predictive Coagulation Assay for the Antithrombotic Activity of Argatroban in the Rat. Thrombosis and Haemostasis. 79(1). 228–233. 9 indexed citations
14.
Lunven, Catherine, et al.. (1996). Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin. British Journal of Pharmacology. 118(3). 727–733. 9 indexed citations
15.
Berry, Christopher M., et al.. (1996). Antithrombotic Activity of Argatroban in Experimental Thrombosis in the Rabbit. Seminars in Thrombosis and Hemostasis. 22(3). 233–241. 13 indexed citations
16.
Lunven, Catherine, et al.. (1996). Inhibition by Argatroban, a Specific Thrombin Inhibitor, of Platelet Activation by Fibrin Clot-associated Thrombin. Thrombosis and Haemostasis. 75(1). 154–169. 28 indexed citations
17.
Lunven, Catherine, et al.. (1994). Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin. Thrombosis and Haemostasis. 72(3). 381–386. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ger‐Jan Sanderink Breakdown of academic impact, for papers by H. Ferres Breakdown of academic impact, for papers by H. Narjes Breakdown of academic impact, for papers by Patricia W. Bedard Breakdown of academic impact, for papers by Janice Rischke Breakdown of academic impact, for papers by Richard T. Dean Breakdown of academic impact, for papers by Yvonne Pak Breakdown of academic impact, for papers by Maria T. Stranieri Breakdown of academic impact, for papers by Valeria Chu Breakdown of academic impact, for papers by Dirk Garmann
Rankless by CCL
2026